Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-11-06
2007-11-06
O'Hara, Eileen B. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C536S023500, C435S320100, C435S069100
Reexamination Certificate
active
10650507
ABSTRACT:
The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and transformed cells, methods of diagnosis and of selection of compounds which can be used as medicament for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension, and more generally the various pathologies associated with abnormalities in the metabolism of cytokines.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5635373 (1997-06-01), Wozney et al.
patent: 6126939 (2000-10-01), Eisenbach-Schwartz et al.
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 2002/0165154 (2002-11-01), Bihain et al.
patent: 2003/0100500 (2003-05-01), Fruebis et al.
patent: 2004/0067881 (2004-04-01), Fruebis et al.
patent: WO 96/30400 (1996-10-01), None
patent: WO 96/34981 (1996-11-01), None
patent: WO 96/39429 (1996-12-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO 98/01257 (1998-01-01), None
patent: WO 98/20165 (1998-05-01), None
Steingrimsson et al., Database UniProt—7.2, Accession No. Q61148, Nov. 1, 1996 (sequence alignment).
Vukicevic et al., 1996, PNAS USA 93:9021-9026.
Alexeev and Yoon “Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide,”Nature Biotech. (1998), vol. 16, pp. 1343-1346.
Austin, et al. “Hypertriglyceridemia as a Cardiovascular Risk Factor,”Am. J. Cardiol. (1998), vol. 81, pp. 7B-12B.
Baldo, et al. “The Adipsin-Acylation Stimulating Protein System and Regulation of Intracellular Triglyceride Synthesis,”J. Clin. Invest. (1993), vol. 92, pp. 1543-1547.
Bartles, J.R., et al. “Biogenesis of the Rate Hepatocyte Plasma Membrane,”Methods Enzymol. (1990), vol. 191, pp. 825-841.
Bihain, et al. “Characterization and purification of the lipolysis-stimulated receptor,” INSERM U391, Universite de Rennes.
Bihain, et al. “Free Fatty Acids Activate a High Affinity Saturable Pathway for Degrdation of Low-Density Lipoproteins in Fibroblasts from a Subject Homozygous for Familial Hypercholesterolemia,”Biochemistry(1992), vol. 31, No. 19, pp. 4628-4636.
Brendel, V. et al. “Methods and algorithms for statistical analysis of protein sequences,”Proc. Natl. Acad. Sci. USA(1992), vol. 89, pp. 2002-2006.
Chen, W.J. et al. “NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor,”J. Biol. Chem. (1990), vol. 265, pp. 3116-3123.
Cole-Strauss et al. “Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide,”Science(1996), vol. 273, pp. 1386-1389.
Davis, C.G. et al. “The J.D. Mutation in Familial Hypercholesterolemia: Amino Acid Substitution in Cytoplasmic Domain Impedes Internalization of LDL Receptors,”Cell(1986), vol. 45, pp. 15-24.
Dietrich, J. et al. “CD3yContains a Phosphoserine-Dependent Di-Leucine Motif Involved in Down-Regulation of the T Cell Receptor,”EMBO Journal(1994), vol. 13, pp. 2156-2166.
Everhart, J.E. “Weight Change and Obesity After Liver Transplantation: Incidence and Risk Factors,”Liver Transpl. Surg. (1998), vol. 4, pp. 285-296.
Freeman, Jr., W.E. “Hypertriglyceridemia and Atherosclerosis,”Annals of Internal Med. (1998), vol. 128, No. 1, pp. 73-74.
Ghebrehiwet, et al. “Isolation, cDNA Cloning, and Overexpression of a 33-kD Cell Surface Glycoprotein that Binds to the Globular “Heads” of C1q,”J. Exp. Med. (1994), vol. 179, No. 6, pp. 1809-1821.
Goldstein, J.L., et al. “Familial Hypercholesterolemia,” inThe Metabolic and Molecular Bases of Inherited Disease(vol. II, 7thed., Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, B. editors, 1995), pp. 1981-2030; McGraw-Hill; New York, New York, USA.
Goldstein, et al. “Hyperlipidemia in Coronary Heart Disease,”J. Clin. Invest. (1973), vol. 52, pp. 1533-1543.
Gura, et al. “Obesity Sheds Its Secrets,”Science(1997), vol. 275, pp. 751-753.
Hayward, et al. “The cDNA Sequence of Human Endothelial Cell Multimerin,”J. Biol. Chem. (1995), vol. 270, pp. 18246-18251.
Henrion, et al. “Structure, Sequence and Chromosomal Location of the Gene for USF2 Transcription Factors in Mouse,”Genomics(1995), vol. 25, pp. 36-43.
Herz, J., et al. “Surface Location and High Affinity for Calcium of a 500-kd liver Membrane Protein Closely Related to the LDL-receptor Suggest a Physiological Role as Lipoprotein Receptor,”European Molecular Biology Laboratory(1988), vol. 7, pp. 4119-4127.
Honore, B., et al. “Cloning and Expression of a cDNA Covering the Complete Coding Region of the P32 subunit of Human pre-mRNA Splicing Factor SF2,”Gene(1993), vol. 134, pp. 283-287.
Hu, E., et al. “AdipoQ is a Novel Adipose-specific Gene Dysregulated in Obesity,”J. Biol. Chem. (1996), vol. 271, No. 18, pp. 10697-10703.
Huettinger, M., et al. “Charecteristics of Chlylomicron Remnant Uptake into Rat Liver,”Clin. Biochem. (1988), vol. 21, pp. 87-92.
Karpe, F., et al. “Clearance of Lipoprotein Remnant Particles in Adipose Tissue and Muscle in Humans,”J. Lipid, Res. (1997), vol. 38, pp. 2335-2343.
Karpe, F., et al. “Magnitude of Alimentary Lipemia is Related to Intima-media Thickness of the Common Carotid Artery in Middle-aged Men,”Elsevier Science Ireland(1998), vol. 141, pp. 307-314.
Krainer, A.R., et al. “Functional Expression of Cloned Human Splicing Factor SF2: Homology to RNA-Binding Proteins, U1 70K, and Drosophila Splicing Regulators,”Cell(1991), vol. 66, pp. 383-394.
Lee, M. G-S., et al. “Charecterization of a cDNA Encoding a Cysteine-Rich Cell Surface Protein Located in the Flagellar Pocket of the ProtozoanTrypanosoma brucei,” Molec. Cell. Biol. (1990), vol. 10 pp. 4506-4517.
Letourneur, F., et al. “A Novel Di-Leucine Motif and a Tyrosine-Based Motif Independently Mediate Lysosomal Targeting and Endocytosis of CD3 Chains,”Cell(1992), vol. 69, pp. 1143-1157.
Lewis, G.F., et al. “Postprandial Lipoprotein Metabolism in Normal and Obese Subjects: Comparison after the Vitamin A Fat-Loading Test,”J. of Clinic. Endo. (1990), vol. 71, pp. 1041-1050.
Lin, et al. “Archaic Structure of the Gene Encoding Transcription Factor USF,”Journal of Biological Chemistry(1994), vol. 269, No. 19, pp. 23894-28903.
Liu, Q., et al. “Design of Polydactyl Zinc-finger Proteins for Unique Addressing within Complex Genomes,”Proc. Natl. Acad. Sci. USA(1997), vol. 94, pp. 5525-5530.
Maeda, et al. “cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1),”Biochem. And Biophys. Research Comm. (1996), vol. 221, pp. 286-289.
Mahley, R.W., et al. “Type III Hyperlipoproteinemia (Dysbetalipoproteinemia): The Role of Apolipoprotein E in Normal and Abnormal Lipoprotein Metabolism,”The Molecular Basis of Inherited Disease(1995), pp. 1953-1980; Scriver CR, Beaudet, A.L., Sly, W.S., Valle, D., editors; McGraw-Hill; New York.
Mann, et al. “Mechanism of Activation and Functional Significance of the Lipolysis-Stimulated Receptor. Evidence for Role as Chylomiscron Remnant Receptor,”Biochemistry(1995), vol. 34, No. 33, pp. 10421-10431.
Massie, et al. “Inducible Overexpression of a Toxic Protein by an Andenovirus Vector with a Tetracycline-Regulatable Expression Cassette,”Journal of Virology(1998), vol. 72, pp. 2289-2296.
Montague, et al. “Congen
Bihain Bernard
Bougueleret Lydie
Yen-Potin Frances
Institut National de la Sante de la Recherche Medicale (INSERM)
O'Hara Eileen B.
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
LSR receptor, its activity, its cloning, and its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with LSR receptor, its activity, its cloning, and its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LSR receptor, its activity, its cloning, and its... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840135